STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 96 filers reported holding STOKE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $257,000 | +97.7% | 20,000 | +100.0% | 0.00% | – |
| Q2 2022 | $130,000 | -41.4% | 10,000 | 0.0% | 0.00% | -100.0% |
| Q1 2022 | $222,000 | +8.3% | 10,000 | +9.9% | 0.00% | – |
| Q4 2021 | $205,000 | -9.7% | 9,100 | +2.2% | 0.00% | -100.0% |
| Q3 2021 | $227,000 | -22.0% | 8,900 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $291,000 | -11.3% | 8,900 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $328,000 | -37.3% | 8,900 | 0.0% | 0.00% | -50.0% |
| Q4 2020 | $523,000 | +72.6% | 8,900 | 0.0% | 0.00% | +100.0% |
| Q3 2020 | $303,000 | – | 8,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 296,822 | $7,551,000 | 1.86% |
| RTW INVESTMENTS, LP | 3,644,248 | $92,710,000 | 1.40% |
| Cormorant Asset Management, LP | 1,278,276 | $32,519,000 | 1.32% |
| Redmile Group, LLC | 2,381,958 | $60,597,000 | 1.06% |
| HighVista Strategies LLC | 47,594 | $1,211,000 | 0.80% |
| Birchview Capital, LP | 15,000 | $382,000 | 0.26% |
| GILDER GAGNON HOWE & CO LLC | 1,123,355 | $28,578,000 | 0.15% |
| Artal Group S.A. | 250,000 | $6,360,000 | 0.14% |
| Tekla Capital Management LLC | 99,263 | $2,525,000 | 0.08% |
| Casdin Capital, LLC | 120,000 | $3,053,000 | 0.08% |